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The postgenomic era has revolutionized approaches to defining host-pathogen interactions and the inves-
tigation of the influence of genetic variation in either protagonist upon infection outcome. We analyzed
pathology induced by infection with two genetically distinct Trypanosoma brucei strains and found that
pathogenesis is partly strain specific, involving distinct host mechanisms. Infections of BALB/c mice with one
strain (927) resulted in more severe anemia and greater erythropoietin production compared to infections with
the second strain (247), which, contrastingly, produced greater splenomegaly and reticulocytosis. Plasma
interleukin-10 (IL-10) and gamma interferon levels were significantly higher in strain 927-infected mice,
whereas IL-12 was higher in strain 247-infected mice. To define mechanisms underlying these differences,
expression microarray analysis of host genes in the spleen at day 10 postinfection was undertaken. Rank
product analysis (RPA) showed that 40% of the significantly differentially expressed genes were specific to
infection with one or the other trypanosome strain. RPA and pathway analysis identified LXR/RXR signaling,
IL-10 signaling, and alternative macrophage activation as the most significantly differentially activated host
processes. These data suggest that innate immune response modulation is a key determinant in trypanosome
infections, the pattern of which can vary, dependent upon the trypanosome strain. This strongly suggests that
a parasite genetic component is responsible for causing disease in the host. Our understanding of trypanosome
infections is largely based on studies involving single parasite strains, and our results suggest that an
integrated host-parasite approach is required for future studies on trypanosome pathogenesis. Furthermore,
it is necessary to incorporate parasite variation into both experimental systems and models of pathogenesis.
The African trypanosomes Trypanosoma congolense, T.
vivax, and T. brucei infect a broad range of mammals across a
wide swathe of sub-Saharan Africa and result in significant
losses to domestic livestock. Sixty million cattle are at risk (as
well as significant numbers of small ruminants and equines),
and the financial burden to agriculture is estimated at $1,300
million/annum (73). In addition, T. brucei subspecies also cause
approximately 20,000 cases of human African trypanosomiasis
per year (85), although this number is undoubtedly a substan-
tial underestimate (14). Given that the production of vaccines
is a very unlikely prospect, coupled with a significant and rising
incidence of resistance to trypanocidal drugs, new routes to
identifying intervention strategies are urgently needed. In this
context, understanding the mechanisms by which the disease is
caused may provide a possible route for therapeutic interven-
tion and/or disease control (1).
One approach, in cattle, has been to identify genetic loci
associated with the control of disease in “trypanotolerant” host
animals, which remain infected but do not display the severe
pathology normally associated with trypanosome infection.
This approach is intended to enable more-informed breeding
strategies to increase the trypanotolerance of the cattle popu-
lation as a whole while increasing productivity and lessening
the disease burden. Trypanotolerance is fundamentally a re-
duction in the pathogenic consequences of infection, and un-
derstanding pathogenesis is therefore important for develop-
ing methods of disease control. This phenotype, with respect to
T. congolense, has been examined in cattle (50, 51) and labo-
ratory mice (48, 49), and genetic loci involved in host control of
trypanosome infections have been identified in both host sys-
tems (20, 32). Host genetic variation is also implicated in dif-
ferences in the severity of human African trypanosomiasis (11,
39). In contrast, the potential impact of parasite genetic vari-
ation upon disease severity and progression has received less
attention. The classically described differences in humans in-
fected with different subspecies of T. brucei are well recog-
nized, with T. brucei rhodesiense causing acute disease and T.
brucei gambiense causing a more chronic infection (2). How-
ever, there is also a range of clinical outcomes within these two
subspecies: for example, the “mild” and “severe” T. b. rhod-
esiense disease observed in geographically different foci (63).
Different parasite genotypes have been identified (23) and
suggested to be associated with human African trypanosomia-
sis foci differing in severity between distinct geographical re-
gions, such as Malawi and Uganda (38) but also within a
relatively restricted geographical area of Uganda (39). Al-
though this provides strong circumstantial evidence for a spec-
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trum of pathogenesis influenced by parasite variation, this di-
vergence of clinical signs could potentially be due to the host or
other, as-yet-undetermined, factors (39).
Anemia was long ago identified as one of the key clinical
signs of trypanosomiasis and is associated with infection in all
species of African trypanosomes across many host back-
grounds (28). In cattle infected with T. congolense, control of
anemia is associated with control of parasitemia and is one of
the definitions of trypanotolerance (52, 54). In mice, the cri-
teria for trypanotolerance are subtly different, and susceptible
strains of mice, such as A/J, develop high parasitemias with T.
congolense infections and have early mortality compared to
tolerant C57BL/6 mice, which have longer survival times and
lower parasitemia but, in contrast to trypanotolerant cattle,
develop more-severe anemia (55). The distinction in pathology
is similar between tolerant C57BL/6 and susceptible BALB/c
mice infected with T. b. brucei (43). Although the definitions of
trypanotolerance lead to semantic contrasts between murine
and bovine models, the actual process of induction of anemia
is considered similar across host species (28). However, the
mechanisms by which trypanosome infections instigate anemia
are unclear. The causative processes of trypanosome-induced
anemia have been variously attributed to a direct hemolytic
factor released by trypanosomes (26), variant surface glyco-
protein (VSG) transfer to the red blood cell and subsequent
immune-mediated hemolysis (69), and upregulated erythro-
phagocytosis by the mononuclear phagocytic system (79, 84).
However, the correlation of anemia severity with the host
genetic background in mice and the independence of severity
of clinical signs from the parasite load (43) have led to the
suggestion that anemia associated with inflammation is the
most important mechanism, certainly in T. brucei. Indeed, in-
flammatory cytokines have been heavily implicated in the in-
duction of anemia in trypanosome infections of mice, with
gamma interferon (IFN-), interleukin-10 (IL-10) (21, 57), and
tumor necrosis factor alpha (TNF-) (41, 42) being identified
as key players. However, this situation is further complicated
by the finding that the mechanisms underlying anemia may
well be different between trypanosome species, with evidence
for TNF- being involved in anemia induced by T. b. rhod-
esiense infection but not in anemia induced by T. congolense
infection (53). The latter study highlights the difficulty in di-
rectly comparing studies that have used different host back-
grounds and, equally pertinently, different parasite species,
subspecies, or strains.
The postgenomic era has resulted in a range of technological
and information resources that allow broad questions to be
asked. Microarray technology is one such approach that can
produce detailed information on gene expression and has been
used to dissect pathological processes in parasitic infections
(29, 36, 72). In the context of genetic variation and parasite
infections, several studies have concentrated on differences
between hosts that are susceptible or tolerant to a particular
parasite. In T. congolense infections, cytokine mRNA expres-
sion differences have been analyzed between peripheral blood
mononuclear cells from NDama (trypanotolerant) and Boran
(trypanosusceptible) cattle (61). Also, global expression level dif-
ferences have been compared between livers from T. congolense
infected A/J (trypanosusceptible) and C57BL/6 (trypanotolerant)
mice (34). These studies highlighted differences between host
strains (pro- versus counterinflammatory cytokines being impli-
cated in infection control in cattle and chemokines, complement
components, and interferon receptors in mice). This work has
recently been expanded, with trypanotolerant cattle shown to
have a more rapid and pronounced response to infection in gen-
eral, in terms of the number of regulated genes and the level of
differential expression, than their trypanosusceptible counterparts
(60). Thus, our understanding of the host determinants of try-
panosome susceptibility is expanding rapidly, but currently the
role of parasite variation in disease pathogenesis is limited.
To address this gap, this study compared the differences in
pathology induced by two genetically distinct lines of T. b. brucei,
TREU927 and STIB247, in BALB/c mice. We developed a flu-
orescence-activated cell sorter (FACS)-based method to deter-
mine changes in hematological parameters during trypanosome
infections. Gross organomegaly of the spleen and liver and the
levels of several cytokines previously implicated in trypanosome
infections were measured. We also undertook a microarray study
to compare differences in host gene expression in mice infected
with the two strains of parasite.
MATERIALS AND METHODS
Parasite strains and mouse infections. Infections were carried out using
cloned lines of two pleomorphic strains of T. brucei after recent tsetse fly trans-
mission, genome reference strain TREU927, originally isolated from a tsetse fly
in 1969 (17), and STIB247, isolated from a hartebeeste in 1971 (15) (the two are
hereafter referred to as strains 927 and 247). All of the parasites used readily
infect rodents and are tsetse fly transmissible. Passage of strains in our laboratory
is kept to a maximum of six times in mice from tsetse fly transmission, in order
to maintain tsetse fly transmissibility and minimize artificial selection by growth
in rodents. Parasites were grown from stabilates in a donor ICR mouse (Harlan,
United Kingdom). Parasites in the logarithmic growth phase were harvested
from the donor mouse by terminal exsanguination. The trypanosomes were
counted in triplicate in an improved Neubauer hemocytometer and diluted in
Carter’s balanced salt solution (CBSS) to 1  104 trypanosomes per 0.2-ml
inoculum. Parasites were then inoculated via the intraperitoneal route into the
experimental BALB/c mice (Harlan, United Kingdom). Six mice were infected
per strain, and an equivalent number of uninfected mice were included as
controls. At days 3, 6, 10, and 12 postinfection (p.i.), mice were euthanized and
blood was collected by cardiac puncture for FACS analysis and plasma isolation,
as well as dissection and weighing of the spleen and liver. The spleens were
snap-frozen in liquid nitrogen and stored at 80°C. The maintenance and care
of experimental animals complied with the appropriate legislation, the United
Kingdom Animals (Scientific Procedures) Act of 1986, and with the national and
University of Glasgow maintenance and care guidelines.
FACS analysis of hematological parameters. For the FACS analysis, 5 l
blood was taken into 2 l of 100 U/ml heparin in CBSS. One hundred ninety-
eight microliters of 1% paraformaldehyde in phosphate-buffered saline (PBS),
pH 7.4, was added to the blood, mixed thoroughly, and fixed for 30 min at room
temperature (RT). Then, 745 l thiazole orange (100 ng/ml in PBS, pH 7.4), used
to stain reticulocytes (83), was added to the blood-fixative mixture and allowed
to stain for 1 h in the dark at RT. Fluorescent beads (Countbright absolute
counting beads for flow cytometry; Invitrogen, United Kingdom) were diluted to
1,000 beads/l and sonicated to ensure even mixing. Fifty microliters of the bead
mixture was then added to the blood-thiazole orange preparation (total volume,
1 ml; 50,000 beads/ml).
FACS analysis was carried out with a Becton Dickinson FACScalibur by using
the 488-nm detector for thiazole orange. Data were analyzed using CellQuest
version 3.3. In pilot experiments, parameters for each of the main cell popula-
tions were determined separately, i.e., a known number of fluorescent beads,
bloodstream trypanosomes purified from blood by DE52 (Whatman, United
Kingdom) ion-exchange column (35), and murine red and white blood cells
separated from whole blood by the use of Histopaque (Sigma, United Kingdom).
FACS counts were then compared with manual counts of each cell population by
hemocytometer. Reticulocytes were stained with methylene blue, counted by
hemocytometer, and expressed as a percentage of the total red blood cell num-
bers. Using these preliminary data, the cell populations from infected blood
samples were counted by gating (Fig. 1) and the number of cells per milliliter was
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extrapolated from the number of beads. All samples for FACS analysis were
counted five times, with 10,000 events per run.
Assays for cytokines, EPO, and NO. Plasma samples were collected from the
experimental mice and frozen at 80°C immediately upon collection. Individual
plasma samples were tested separately for the levels of erythropoietin (EPO),
TNF-, IFN-, IL-12, IL-10, and nitric oxide (NO), according to the manufac-
turer’s instructions [all measured using Endogen Colorimetric enzyme-linked
immunosorbent assay (ELISA) kits, except for EPO (Quantikine mouse EPO
immunoassay; R&D Systems) and NO (Griess reagent system; Promega)].
TNF- was also assayed using an independent test according to the manufac-
turer’s instructions (Murine TNF- enzyme immunoassay kit; Promokine).
RNA isolation. Spleens were used as the source of RNA at day 10 p.i., a time
point that demonstrated significant differences in a range of phenotypes—
splenomegaly, hematology parameters, and cytokine levels. Total spleen RNA
was isolated from three spleens per group of mice (strain 927 infected, strain 247
infected, and uninfected) using the RNeasy RNA kit (Qiagen), after lysing the
spleen tissue in RLT buffer (Qiagen) using ceramic beads (lysing matrix D;
Qbiogene) in a RiboLyser centrifuge (Hybaid). RNA quality was checked using
an Agilent 2100 bioanalyzer (Agilent Technologies), and RNA was quantified
using a Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific). RNA
was routinely stored at 80°C. Only RNA with an RNA integrity number (71) of
greater than 9.0 was used for the microarray hybridization.
Microarray hybridization. RNA from each mouse spleen was used to create
first-strand cDNA. cDNA synthesis and microarray hybridization were carried
out at the Sir Henry Wellcome Functional Genomics Facility, University of
Glasgow. Hybridization was performed using the GeneChip Mouse Genome
430A 2.0 Array (Affymetrix).
Real-time PCR. Real-time PCR was carried out on selected genes using the
same RNA as was utilized in the microarray hybridization. Approximately 1 g
of total RNA was treated with TURBO DNase (Ambion) according to the
manufacturer’s protocol. Reverse transcription was carried out using an Omni-
script reverse transcription kit (Qiagen) with 5 M oligo(dT) primers. Real-time
PCRs were carried out in triplicate per individual sample on a 7500 Real-Time
PCR system (Applied Biosystems), using approximately 100 ng cDNA, 1 Power
SYBR Green Master Mix (Applied Biosystems), and the respective oligonucle-
otide primers at 4 M in a final reaction volume of 25 l. Oligonucleotide
primers were designed using Primer Express 3.0 software (Applied Biosystems).
Primers directed against glyceraldehyde 3-phosphate dehydrogenase were used
as the endogenous control (the endogenous control and target gene primer
sequences are shown in Table 1) in order to standardize the expression levels of
target genes. The comparative quantification (CT) was used as a measure of
mRNA differences between each preparation.
Data analysis. Phenotypes were analyzed by two-way analysis of variance
(ANOVA) with the trypanosome strain (strain 927 infected, strain 247 infected,
or uninfected) and day of infection as explanatory variables. Where significant
differences among strains were detected, Tukey’s post hoc analysis determined
which groups were significantly different from each other. For IFN-, the data
were not amenable to parametric statistics, and in these cases, Kruskal-Wallis
analyses of day 10 data were undertaken with correction for tied values where
appropriate. The above-described analyses were all undertaken using MINITAB
v13 software. A post hoc test of the Kruskal-Wallis analysis was done as described
previously (74). Raw microarray data were analyzed at the Sir Henry Wellcome
Functional Genomics Facility, University of Glasgow, by using robust multichip
average normalization (27), followed by calculation of the change in expression
of each gene between arrays using the rank product method (7). Data are
presented using a false-discovery rate (FDR) of1. The microarray study design
used, raw data, and normalized expression values are available on the Gene
Expression Omnibus website (http://www.ncbi.nlm.nih.gov/geo/), series record
number GSE17049. Visualization and clustering analysis of normalized microar-
ray data were carried out using the Multi Experiment Viewer, version 3.1,
included in the TM4 software package from The Institute of Genomic Research
(http://www.tigr.org/). The context of gene up- or downregulation was examined
by using the Ingenuity Pathways Analysis (IPA) web-based software (Ingenuity
Systems, www.ingenuity.com). The functional analysis identified the biological
functions that were most significant in the data set. Genes from the data set with
an FDR of 5 that were associated with biological functions and/or diseases in
the Ingenuity Pathways Knowledge Base were considered for the analysis. Fis-
cher’s exact test was used to calculate a P value determining the probability that
each biological function assigned to that data set is due to chance alone. Canon-
ical Pathways analysis identified the pathways from the IPA library of canonical
pathways that were most significant in the data set. The significance of the
association between the data set and the canonical pathway was measured in two
ways: (i) by determining the ratio of the number of genes from the data set that
map to the pathway divided by the total number of genes in the canonical
pathway and (ii) by using Fischer’s exact test to calculate a P value determining
the probability that the association between the genes in the data set and the
canonical pathway is explained by chance alone.
FIG. 1. Measurement of cell populations by FACS. (Panel i) Forward scatter versus side scatter. Gated cell populations are shown. A,
trypanosomes; B, calibration beads; C, red blood cells; D, white blood cells. (Panel ii) Forward scatter versus FL1 channel. X, reticulocytes stained
by thiazole orange; Y, mature red blood cells.
TABLE 1. Sequences of primers used in quantitative
real-time PCR analyses
Primer Sequence (5–3)
GAPDHf..................................GACCCCTTCATTGACCTCAACT
GAPDHr .................................TCTCGCTCCTGGAAGATG
Ym1f ........................................TTGCGTGACTATGAAGCATTGA
Ym1r ........................................AGGAGTAGAGACCATGGCACTGA
Arg2f ........................................ACCTCTCACCACTGTATCTG
Arg2r ........................................CTCAGGCCAATGTACACAATAT
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RESULTS
Longitudinal infections. To analyze the pathogenesis caused
by infection, groups of inbred BALB/c mice were infected with
strain 927 or 247 and examined at four time points postinfection.
A range of parameters were measured, and the data are summa-
rized in Fig. 2 (for a statistical analysis of these data, see Table S1
in the supplemental material). Mice infected with strain 927 dis-
played a greater reduction in red blood cell numbers compared to
the controls, exhibiting a steady decline as the infection pro-
gressed from day 3 to day 12 p.i. (Fig. 2). The red blood cell
numbers of strain 247-infected mice were only slightly lower than
those of uninfected mice and showed little evidence of a decline
with time. In contrast, reticulocytosis was much more evident in
the strain 247 infections and peaked at day 10 p.i., whereas the
reticulocyte counts were much lower in the strain 927 infections
(Fig. 2). As an adjunct to these hematological parameters, EPO
levels in plasma were measured and were raised in both strains at
day 6 p.i. Thereafter, there was a large increase in EPO levels at
FIG. 2. Phenotypic parameters of strain 927-infected (black bars), strain 247-infected (gray bars), and uninfected (white bars) mice at days 3,
6, 10, and 12 p.i. (mean value 	 1 standard error, n 
 6). For statistical analysis of phenotypes, see Table S1 in the supplemental material.
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day 10 p.i. in mice infected with strain 927, which reduced to
strain 247 levels by day 12 (Fig. 2). The changes in red blood cell
numbers, reticulocytes, and EPO were clearly significantly differ-
ent between infected and uninfected mice and, crucially, between
the mice infected with strain 927 and those infected with
strain 247.
There was massive splenomegaly evident in mice infected
with each strain that increased as the infection progressed
when measured against uninfected controls, with an increase in
strain 247-infected mice of 1,057% on day 12 p.i., compared to
747% for strain 927-infected mice. Differences in hepatomeg-
aly were less clear-cut during the early stages of infection, with
infections with both strains inducing an increase of more than
70% over uninfected controls by day 10 p.i. The degree of
hepatomegaly in the strain 247 infections then reduced slightly
on day 12 p.i., whereas strain 927 induced a further increase
(Fig. 2). The splenomegaly trait showed clear significant dif-
ferences among all three groups. In contrast, hepatomegaly
only was clearly statistically significantly different between the
uninfected and infected groups but not between the infected
groups.
When plasma cytokine levels in the mice were compared, the
levels of IL-10 showed clear significant differences among all
three groups, with levels in strain 927-infected mice signifi-
cantly greater than those in strain 247-infected mice. The levels
of IFN- were greater in infected mice compared with unin-
fected controls but were statistically significantly different only
between strain 927-infected mice and controls. The distinct
differences between the results for strain 927- and 247-infected
mice apparent in Fig. 2 are not statistically significant, in large
part because of the reduced power of the Kruskal-Wallis test
versus two-way ANOVA. The levels of IL-12 were consistently
increased in infected versus uninfected mice at all time points
for both parasite strains, with concentrations in strain 247-
infected mice being greater than those in strain 927-infected
mice. TNF- concentrations were very low, being almost un-
detectable in all of the mice, despite being assayed using dif-
ferent dilutions of plasma and two assay systems (data not
shown). Plasma NO levels similarly showed no differences be-
tween infected mice and uninfected controls (data not shown).
In summary, there is clear evidence that different strains of T.
brucei induce very different patterns of pathogenesis and spe-
cific differences in cytokine levels.
Microarray analysis of infected versus uninfected mice. As
the spleen is the major site of the hematopoietic and reticu-
loendothelial responses, as well as showing a highly significant
strain-specific response to infection, we investigated the
changes in gene expression in this tissue in order to gain insight
into the pathways that could be responsible for the differential
response. The day 10 time point was chosen for this analysis, as
most of the measured parameters (Fig. 2) showed the maximal
strain-specific difference. This approach also offered the op-
portunity to define the common or non-strain-specific re-
sponses. The expression of genes in the spleen was examined
by microarray analysis in three ways: comparison of uninfected
mice and mice infected with T. brucei 927, uninfected versus
strain 247-infected mice, and finally differences between strain
247- and strain 927-infected mice (all using an FDR cutoff1).
As might be expected, there were a considerable number of
genes that were significantly upregulated or downregulated in
both strain 247-infected mice and strain 927-infected mice
versus control mice (Fig. 3). The genes unique to each set of
infections at an FDR of 1 for strain 927-infected versus
uninfected mouse and strain 247-infected versus uninfected
mouse comparisons are shown in Tables S2 and S3 in the
supplemental material (for full lists of the genes and rank
product analysis results, go to http://tinyurl.com/trypmap or
GEO series record number GSE17049). These data show that
59.5% of the genes differentially regulated in response to one
strain were also differentially regulated to a similar degree in
response to the other strain. The biological processes associ-
ated with the genes that were differentially regulated in in-
fected and uninfected mice (as identified by IPA) were also
similar between the strain 247 and 927 infections (Fig. 4), and
as might be expected, the most significantly differentially reg-
ulated functions were the immune response and inflammation,
together with genes associated with the hematological system.
Indeed, the genes that predominate in both infections encode
immunoglobulins (21 of the upregulated genes are immuno-
globulin or immunoglobulin-related genes), which were not
found in the analysis of differential expression between infec-
tions of the two strains, suggesting that the acquired immune
response is upregulated in a similar fashion in both sets of
infections.
Microarray analysis of strain 927- versus strain 247-in-
fected mice. Approximately 40% of the regulated genes (up or
down, FDR of 1) represent differentially expressed strain-
specific responses (Fig. 3). The genes differentially regulated in
the two sets of infected mice are potentially the key to under-
standing the different pathologies observed between infections
with the two trypanosome strains. When analyses were under-
taken to directly compare the gene expression from the strain
927-infected mice with that from the strain 247-infected mice,
there were 62 genes upregulated in strain 927-infected mice
compared to strain 247-infected mice and 39 genes downregu-
lated at an FDR level of 1 (see Tables S4 and S5 in the
supplemental material, respectively). However, this up- or
downregulation is relative to the strain 927 expression value,
and therefore “upregulation” of a gene in strain 927-infected
FIG. 3. The number of genes significantly differentially expressed
(FDR of 1) between trypanosome-infected and uninfected mouse
spleens. The overlap represents commonality in strain 247- and 927-
induced changes relative to uninfected controls, and numbers to the
left and right are the strain-specifically regulated genes at this FDR
level. Panel A represents genes upregulated in strain 927- or 247-
infected mice relative to control mice, and panel B represents genes
downregulated in strain 927- or 247-infected mice relative to control
mice.
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mice compared to strain 247-infected mice could be due to
downregulation of the gene in strain 247-infected mice, and
equally, “downregulation” of genes in strain 927-infected mice
could be due to upregulation of the gene in strain 247-infected
mice. This was investigated by examining the relative expres-
sion values of the differentially regulated genes compared to
control mouse expression values. In fact, 12 of the 62 genes
“upregulated” in strain 927-infected mice compared to strain
247-infected mice are downregulated in strain 247-infected
mice (see Table S4 in the supplemental material) and 3 of the
39 genes “downregulated” in strain 927-infected mice com-
pared to strain 247-infected mice are upregulated in strain
247-infected mice (see Table S5 in the supplemental material).
IPA allows the genes that are differentially regulated to be
placed in a physiological and biochemical context by grouping
them according to pathway or function and also provides an
alternative validation of up- or downregulation, with a corre-
lation of statistical probability of validity with the number of
genes being differentially expressed in the respective pathway.
This analysis demonstrated that the most differentially regu-
lated pathways are lipopolysaccharide/IL-1-mediated inhibi-
tion of retinoid X receptor (RXR) function, liver X receptor
(LXR)/RXR activation, and IL-10 signaling (Fig. 5). These are
interconnected pathways, as evidenced by the genes that are
components of all three pathways (Table 2). This is a striking
result, as it suggests that an interacting network of genes is
differentially stimulated in a strain-specific manner.
Several lines of evidence implicate alternative activation of
macrophages as a major driver of strain-specific pathology.
LXR activation (Fig. 5) has been linked with modulation of
macrophage activation (30, 31). IL-10 (Fig. 2, 5) is a well-
characterized counterinflammatory cytokine, and levels of
IL-10 are important in determining pathogenesis in trypano-
some-infected mice (18, 56). Arg2 transcription is known to be
FIG. 4. Significantly differentially regulated biological functions (A) and canonical pathways (B) between strain 247-infected and uninfected
mice (247 versus C) and between strain 927-infected and uninfected mice (927 versus C), as identified by IPA. The y axis is the negative log of the
Fischer exact test P value for the genes identified with the respective biofunction or canonical pathway. The dashed line indicates the threshold
of significance (P  0.05).
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positively regulated by the LXR pathway (44) and is upregu-
lated as a component of the IL-10 response (Table 2). Arginase
II has a counterinflammatory effect upon macrophages by re-
ducing NO production (44). In light of this evidence, the mi-
croarray output was analyzed for genes that are associated with
alternative macrophage activation (those found to be signifi-
cantly differentially regulated in the data set are listed in Table
3), as a set of genes associated with this process has recently
been characterized in trypanosome and other parasitic infec-
tions (4, 16). There are 16 genes associated with alternative
macrophage activation that are differentially regulated, and all
(apart from IL-4 and IL-4il) are upregulated in strain 927-
infected mice, with Ym1, Arg2, MglI, IL-10, IL1rl1, and Pla2g7
upregulated more than twofold. Fizz1, a gene strongly associ-
ated with the pathway (58, 67, 68), was not up- or downregu-
lated between strain 927- and 247-infected mice. This may be
due to the time of infection (early versus late), as Fizz1 is
expressed later in infection, at least in C57BL/6 mice (58). It
may also be due to the fact that spleen RNA was used, rather
than RNA from purified macrophages, as has been the case in
previous studies (16, 58). Both Arg2 and Ym1 induced much
stronger differential signals than Fizz1 when purified macro-
phages from infected and uninfected mice were compared
FIG. 5. Canonical pathways significantly differentially regulated in
strain 247- and strain 927-infected mice. The bar chart shows the
Fischer exact test P values determining the probability that the asso-
ciation between the genes in the data set and the canonical pathway is
explained by chance alone (the significance threshold of P  0.05 is
indicated by the dashed line).
TABLE 2. Significantly differentially expressed genes associated with the three most significantly differentially expressed canonical pathways,
i.e., LPS/IL-1-mediated inhibition of RXR function, LXR/RXR activation, and IL-10 signaling
Pathway and gene Description FDRd FCe
LPS/IL-1-mediated inhibition of RXR
functiona
ApoE Apolipoprotein E 2.42 2.1
Acsl6 Acyl coenzyme A synthetase long-chain family member 6 0 5.0
ApoC2 Apolipoprotein C-II 0.7 2.7
IL4i1 IL-4-induced 1 2.16 2.1
Hmgcs2 3-Hydroxy-3-methylglutaryl coenzyme A synthase 2 (mitochondrial) 1.2 2.9
IL1r2 IL-1 receptor, type II 0.08 5.8
Mgst2 Microsomal glutathione S-transferase 2 3.48 2.0
Gsta4 Glutathione S-transferase A4 0.73 2.7
Sult1A1 Sulfotransferase family, cytosolic, 1A, phenol preferring, member 1 2.23 2.5
CD14 CD14 molecule 0.26 3.7
Xpo1 Exportin 1 (CRM1 homolog, yeast) 2.98 2.3
Pltp Phospholipid transfer protein 2.63 2.1
Abcc3 ATP-binding cassette, subfamily C (CFTR/MRP), member 3 2.81 2.1
Aldh6A1 Aldehyde dehydrogenase 6 family, member A1 3.81 2.0
LXR/RXR activationb
IL1r2 IL-1 receptor, type II 0.08 5.8
ApoE Apolipoprotein E 2.42 2.1
IL1rN IL-1 receptor antagonist 3.87 2.0
CD14 CD14 molecule 0.26 3.7
ApoC2 Apolipoprotein C-II 0.7 2.7
Arg2 Arginase, type II 0 6.7
Pltp Phospholipid transfer protein 2.63 2.1
IL-10 signalingc
IL1r2 IL-1 receptor, type II 0.08 5.8
Fos v-fos FBJ murine osteosarcoma viral oncogene homolog 0.11 5.2
IL1rN IL-1 receptor antagonist 3.87 2.0
CD14 CD14 molecule 0.26 3.7
Arg2 Arginase, type II 0 6.7
Fcgr2B Fc fragment of immunoglobulin G, low-affinity IIb, receptor (CD32) 1.79 2.3
a Log P value, 5.66E  00 (Fischer’s exact test for significance of pathway [see Materials and Methods]).
b Log P value, 3.76E  00 (Fischer’s exact test for significance of pathway [see Materials and Methods]).
c Log P value, 3.13E  00 (Fischer’s exact test for significance of pathway [see Materials and Methods]).
d Only genes with FDRs of 5 are included.
e FC, fold change in gene expression between strain 927-infected and strain 247-infected mice.
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(58), suggesting that expression of these genes is more likely to
be detected in RNA from a mixed cell population. To validate
the alternative macrophage data from the microarray analysis,
a quantitative real-time PCR was also carried out against two
of the most differentially regulated genes involved in alterna-
tive macrophage activation, Ym1 and Arg2. The differences in
the expression levels of these genes detected by real-time PCR
correlated with the microarray differences, with strain 927-
infected mice showing a similar fold increase in expression
over strain 247-infected mice (Fig. 6). In addition, ELISA
results examining day 10 levels of IL-10 (Fig. 2) correlate with
microarray differences.
One of the main phenotypes analyzed in the experimental
mice was anemia, with strain 927-infected mice showing signif-
icantly greater anemia than strain 247-infected mice and,
conversely, strain 247-infected mice generating significantly
greater reticulocytosis (Fig. 2). Genes associated with the he-
matological system, as identified from the Ingenuity database,
were among the most significantly differentiated between in-
fections with the two trypanosome strains (Table 4). Several
genes that are implicated in the hematopoietic response were
upregulated in strain 247-infected mice compared to strain
927-infected mice (presented as negative fold changes in Table
4). Chief among these genes are those for Kru¨ppel-like factor
1 (Klf1), which coordinates erythroid cell proliferation and
plays a role in hemoglobinization (8); erythrocyte membrane
protein band 4.2 (Ebp4.2), also implicated in erythropoiesis
(87); and dematin (Ebp4.9), which is implicated in maintaining
the functional integrity of erythrocytes, the disruption of which
is associated with anemia (33). Also upregulated is the gene for
acetylcholinesterase (Ache), which has also been implicated in
the expansion and proliferation of primary bone marrow cells
(75). The Duffy antigen/receptor for chemokines (Darc) is also
upregulated in strain 247-infected mice and has been suggested
to play a role in controlling inflammation by acting as a che-
mokine sink (12). In contrast, the erythropoietic genes are
downregulated in strain 927-infected mice, and the majority of
the genes associated with the hematological system that are
upregulated in strain 927-infected mice are immunological/
inflammatory response associated. The splenic gene expression
data, together with the reticulocyte measurements (Fig. 2),
suggest that extramedullary hematopoiesis is occurring to a
greater extent in strain 247-infected mice than in strain 927-
infected mice, and this may be compensating for any loss of red
blood cells in the strain 247 infections.
Taken together, our data point toward the balance of pro-
and counterinflammatory responses influencing the course of
pathogenesis in mice, resulting in the strain 927-infected mice
displaying a more severe and chronic anemia, associated with
splenic alternative macrophage activation and increased ex-
pression of IL-10 and RXR/LXR. In contrast, the strain 247-
infected mice are able to control their anemia and mount a
reticulocytosis associated with higher plasma IL-12 levels.
These data suggest that the innate immune response is a key
determinant of strain-specific pathogenesis.
DISCUSSION
The differential pathogenesis induced by different parasite
strains provides a route to dissecting the mechanisms of para-
site control by the host and the disease-causing pathways in-
duced by virulent parasites. We have demonstrated significant
FIG. 6. Real-time PCR of the Ym1 (A) and Arg2 (B) genes. Real-
time results are presented as relative quantification (RQ) with respect
to control sample 1. Control reactions 1 to 3 were carried out with
RNA from uninfected control mice, strain 927 reactions 1 to 3 used
RNA extracted from mice infected with strain 927, and strain 247
reactions 1 to 3 used RNA from mice infected with strain 247. Negative
controls (absence of reverse transcriptase and no-template controls)
were all negative in each case (data not shown).
TABLE 3. Significantly differentially expressed genes associated
with alternative activation of macrophagesa
Gene Product FCb
Arg2 Arginase, type II 6.7
Ym1 Chitinase 3-like 3 5.6
Pla2g7 Phospholipase A2, group VII 2.4
IL-10 IL-10 2.1
MglI C-type lectin domain family 10, member A 2.1
IL1rl1 IL-1 receptor-like 1 2.1
Il1rn IL-1 receptor antagonist 2.0
IL4i1 IL-4-induced 1 2.0
Socs3 Suppressor of cytokine signaling 3 2.0
Tgfb3 TGF- 3 1.9
Tgfbi TGF--induced, 68 kDa 1.7
F13a1 Coagulation factor XIII, A1 polypeptide 1.5
IL4r IL-4 receptor 1.6
Arg1 Arginase, liver 1.6
IL-4 IL-4 1.3
Ptges Prostaglandin E synthase 1.3
a Only genes that were significantly differentially regulated are shown. For
more details of genes associated with alternatively activated myeloid cells, see
references 4, 6, 9, 16, and 62.
b FC, fold change in gene expression between strain 927-infected and strain
247-infected mice.
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differences in the pathology induced by two genetically distinct
parasite strains. Importantly, we have shown that different
pathways are induced by the two strains and that the strain-
specific pathogenesis is not simply due to a difference in the
magnitude of the same pathways. Our results will include any
host responses caused by any differences in growth rate and
parasitemia between strains 927 and 247 (81), but we predict
that these would be minor given that several studies have
indicated a lack of correlation between parasite numbers and
host pathology, both in mice infected with T. brucei (22, 43)
and in trypanotolerant and susceptible cattle infected with T.
congolense (64).
Three main findings arise from our data: the common ex-
pression profiles between the infections of genes related to the
adaptive immune response, the differential regulation of genes
associated with the hematological system and anemia, and the
differential expression of genes associated with the inflamma-
tory response and their association with the progression of
pathogenesis.
Adaptive immune response. The adaptive immune response
is significantly differentially expressed between infected mice
and uninfected controls, but the associated genes are not dif-
ferentially expressed between strain 927- and 247-infected
mice. The upregulation of genes associated with the adaptive
immune response is expected, as trypanosomes provoke a
strong and persistent antibody response, particularly against
the surface-expressed and abundant VSGs (46). Interestingly,
a recent study indicated that there was trypanosome-induced
loss of memory responses in the spleen, probably by induction
of apoptosis in splenic B cells (65). We examined the expres-
sion profiles of the genes identified as being differentially ex-
pressed during the splenic remodeling and inhibition of B-cell
responsiveness, and in both the strain 927 and 247 infections,
these genes were either downregulated (Bcl2, Baff, Baff-R) or
upregulated (caspase-3), but there were no differences between
infections with the two strains. This confirms that a trypano-
some-driven disruption of the B-cell response is occurring, but
it is common to both parasite strains and so is not responsible
for the differential pathogenesis.
Anemia. Much of the pathology we have measured is asso-
ciated with the hematological system and anemia. In other
studies, pathology associated with anemia does not correlate
with the overall ability of mice to survive infections; for exam-
ple, trypanotolerant C57BL/6 mice exhibit more-severe anemia
TABLE 4. Genes associated with the hematological system that are differentially expressed in strain 927-infected
mice and strain 247-infected mice
Gene Product Location Type FCb
Achea Acetylcholinesterase Plasma membrane Enzyme 2.1
Aicdaa Activation-induced cytidine deaminase Cytoplasm Enzyme 1.9
ApoEa Apolipoprotein E Extracellular space Transporter 2.1
Art2A ADP-ribosyltransferase 2a Extracellular space Enzyme 1.9
C3ar1 Complement component 3a receptor 1 Plasma membrane G-protein-coupled receptor 1.9
C5ar1 Complement component 5a receptor 1 Plasma membrane G-protein-coupled receptor 1.8
Ccl3 Chemokine (C-C motif) ligand 3 Extracellular space Cytokine 2.2
Ccl8 Chemokine (C-C motif) ligand 8 Extracellular space Cytokine 2.2
Ccr6 Chemokine (C-C motif) receptor 6 Plasma membrane G-protein-coupled receptor 2
CD14 CD14 molecule Plasma membrane Transmembrane receptor 3.7
CD22a CD22 molecule Plasma membrane Other 2.3
CD71a CD71 molecule Plasma membrane Transporter 2.3
CD80 CD80 molecule Plasma membrane Transmembrane receptor 2.4
CD163 CD163 molecule Plasma membrane Transmembrane receptor 1.9
Cr2a Complement component receptor 2 Plasma membrane Transmembrane receptor 3.0
Ctla4 Cytotoxic T-lymphocyte-associated protein 4 Plasma membrane Other 4.4
Ctsl2 Cathepsin L2 Cytoplasm Peptidase 2.4
Cxcl3 Chemokine (C-X-C motif) ligand 3 Extracellular space Cytokine 6.1
Cxcr7 Chemokine (C-X-C motif) receptor 7 Plasma membrane G-protein-coupled receptor 3.6
Darca Duffy blood group, chemokine receptor Plasma membrane G-protein-coupled receptor 3.8
Dusp1 Dual-specificity phosphatase 1 Nucleus Phosphatase 2.8
Epb42a Erythrocyte membrane protein band 4.2 Plasma membrane Transporter 4.7
Epb49a Erythrocyte membrane protein band 4.9 (dematin) Plasma membrane Other 3.2
F7 Coagulation factor VII (serum prothrombin conversion accelerator) Plasma membrane Peptidase 2.8
Fcgr2b Fc fragment of immunoglobulin G, low-affinity IIb, receptor (CD32) Plasma membrane Transmembrane receptor 2.3
Fos v-fos FBJ murine osteosarcoma viral oncogene homolog Nucleus Transcription regulator 5.2
Fprl1 Formyl peptide receptor 2 Plasma membrane G-protein-coupled receptor 2.0
Gna13 Guanine nucleotide binding protein (G protein), alpha 13 Plasma membrane Enzyme 2.8
Igh-1A Immunoglobulin heavy chain 1a (serum immunoglobulin G2a) Extracellular space Other 1.9
IL1rl1 IL-1 receptor-like 1 Plasma membrane Transmembrane receptor 2.1
IL1rN IL-1 receptor antagonist Extracellular space Cytokine 2.0
IL4Iia IL-4-induced 1 Cytoplasm Enzyme 2.0
Klf1a Kru¨ppel-like factor 1 (erythroid) Nucleus Transcription regulator 4.1
Lcn2 Lipocalin 2 Extracellular space Transporter 1.9
Lilrb4 leukocyte immunoglobulin-like receptor, subfamily B (with TM and
ITIM domains), member 4
Plasma membrane Other 2.0
a Gene upregulated in strain 247-infected mice compared to strain 927-infected mice.
b FC, fold change.
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than their trypanosusceptible counterparts and yet clearly are
better able to survive infections (55). It has been shown pre-
viously that strain 927-infected mice develop clinical symptoms
of disease much more rapidly than strain 247-infected mice
and had to be removed from experiments on humane grounds
earlier (the average time point for humane termination of
infection was 29 days for strain 927-infected mice, compared to
45 days for strain 247-infected mice [81]). This study serves as
a proxy survival assay and suggests that, in the case of these two
strains of T. brucei, the pathology we are observing correlates
with decreased survival.
Our data suggest that in the case of strain 247-infected mice,
erythropoiesis may be compensating for any drop in red blood
cell numbers, as there is a significant reticulocytosis and a
greater degree of splenomegaly in strain 247-infected mice,
accompanied by a limited drop in red blood cell counts. In
contrast, in strain 927 infections, the red blood cell counts
decrease much more markedly, and although there is a rise in
EPO levels, there is very little detectable reticulocyte response
coupled with more limited splenomegaly. The spleen has been
identified as a major center of erythropoiesis in response to
parasitic infection, in particular, malaria, but is also a major
center for the mononuclear phagocytic system (13). Therefore,
one could postulate that the general increase in mass in both
infected spleens is due to the responsive phagocytic compart-
ment and the additional increase in strain 247-infected spleens
is due to the erythropoietic stimulation. Dyserythropoiesis has
been suggested to play a role in anemia due to trypanosome
infection, and the suppressive activity of infection-induced NO
or cytokines has been implicated (22, 37), particularly early in
infection (3). The microarray results in our study suggest that
dyserythropoiesis is occurring in the strain 927-infected mice.
However, negligible levels of NO were detected in plasma
although IFN- and IL-10 plasma levels were associated with
the more severe anemia. Both IFN- and IL-10 have suppres-
sive effects upon erythropoiesis (10, 45), and we hypothesize
that the anemia observed in the strain 927-infected mice is due
to the suppression of erythropoiesis as a consequence of the
increased expression of these cytokines.
Our findings on splenic hematological gene expression bear
interesting comparison with the recent studies of the effects of T.
congolense infections on anemia in trypanotolerant and trypano-
susceptible mice (59). The trypanotolerant mice (C57BL/6) dis-
play more-severe anemia than trypanosusceptible mice (AJ or
BALB/c), and recovery from anemia is correlated with spleen
size, a feature also observed in our data. It was found that the
erythropoietic and innate immune responses played crucial
roles in the differential anemia observed but that the acquired
immune response was not implicated (59), in concordance with
our findings on T. brucei. The genes associated with a reduced
erythropoietic response in C57BL/6 mice in response to T.
congolense infection, namely, those for structural proteins
(spectrin and glycophorin) and transcription factors (Lmo2,
Zfpm1, Klf1, and Tcfe2a), were also expressed at lower levels in
the spleens of BALB/c mice infected with strain 927-infected
compared with strain 247-infected BALB/c mice (all significant
at an FDR of5). Iron homeostasis has also been suggested to
play a role in trypanosome-induced anemia (59, 77), and we
found some evidence for this in our study. Most of the genes
previously identified were either not differentially expressed
relative to control mice (hepcidin, ferritin, Dmt-1, Fpn-1, Fhc,
CD16, CD91) or not differentially expressed between infec-
tions with the two trypanosome strains (Hmox-1, ceruloplas-
min, CD36, and transferrin, all downregulated to similar levels
in both infections). However, the genes for transferrin recep-
tors 1 and 2 (Tf-R1 and Tf-R2), which are major determinants
maintaining iron homeostasis, were both significantly upregu-
lated in strain 247-infected mice compared to strain 927-in-
fected mice. Of these two genes, Tf-R1 was highly significantly
differentially expressed (3.0-fold change) at day 10, in agree-
ment with previous data on the upregulation of this gene in the
acute stage of infection (77). In the latter study and others
(76), the acute stage of infection was associated with type 1
cytokines, but in the present study, the picture is less clear, as
the anemic mice expressed both a type 2 (IL-10-dominated
response) and a type 1 cytokine (IFN-). Therefore, from our
data, there is some suggestion that iron homeostasis plays a
role in the anemia seen, but this conclusion may well depend
upon the strain of trypanosome used. Our data combine to
suggest that strain 247-infected mice are mounting a greater
erythropoietic response to counter the drop in red blood cell
numbers than strain 927-infected mice, whereas the anemia
observed in strain 927-infected mice is associated with the
inflammatory response and an associated inability to stimulate
erythropoiesis.
Inflammation. One of the keys to the strain-specific patho-
genesis seems to be the role of the IL-10-dominated counter-
inflammatory response linked to alternative macrophage acti-
vation. This pathway has also been identified as crucial in
determining susceptibility in murine leishmaniasis (24). In ad-
dition, the LXR genes also contribute to modulation of mac-
rophage activation, leading to counterinflammatory suppres-
sion of NO production (44). This indicates that the degree to
which the initial inflammatory response is modulated may be a
key determinant of the inflammatory response of the host (66).
In our studies, infections with strain 927 where the IL-10/
alternative macrophage dominated were those that displayed
greater pathology. In previous studies, alternative macrophage
activation has been implicated in T. brucei infections (4), but it
has been suggested that these pathways result in amelioration
of type 1-driven pathology (4, 18), and arginase II has been
identified as differentially activated by different strains of T. b.
gambiense in mice and is associated with differences in pathol-
ogy (25). The role of both IL-10 and alternative macrophages
in controlling pathology induced by trypanosomes has also
been identified in T. congolense infections (4, 68). In addition,
LXR and RXR, involved in the two most differentially regu-
lated pathways between strain 927- and 247-infected mice (Fig.
5), are important determinants of the fate of macrophages and
are thought to play a role in innate immunity to microbes (82,
86). Modulation of macrophage activation has been heavily
implicated in the control of trypanosome infections, and the
direction of polarization has been suggested to be the key in
determining disease outcome (76). The linking of the identi-
fied pathways to pathology may be dependent upon the timing
of the transition from proinflammatory cytokines, which are
essential for controlling the parasites in the early stage of
infection (21), to a counterinflammatory response that limits
the pathology that would result from a prolonged proinflam-
matory environment (5, 18, 19, 76). In the context of our data,
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it may be that this switch occurs at different points, or the
dynamics of the switch differ between infections with strain 247
or 927, and examining the cytokine/gene expression dynamics
over a longer time course of infection may give further insight
into the role that this switch plays in strain-specific pathogen-
esis. Our data certainly suggest that using parasite strains that
differ in pathogenicity will prove a useful tool in this respect.
One surprising and perhaps contradictory finding is the stim-
ulation of both pro- and counterinflammatory cytokines in the
strain 927-infected mice (IFN- and IL-10) that are both less
upregulated in the strain 247-infected mice, which, in contrast,
display consistently greater concentrations of IL-12. The cyto-
kines were measured directly from plasma and not from cells
isolated from the spleen. The plasma may have cytokines con-
tributed from multiple organs and tissues and therefore may
not be representative of what is occurring in the spleen. Cer-
tainly, the microarray studies suggest that neither IL-12 nor
IFN- is significantly differentially expressed in the spleen.
This apparently paradoxical pattern of cytokine expression is a
finding that requires further investigation, and the cellular
source of the plasma cytokines would ideally be identified.
The results presented here clearly demonstrate that there
are significant differences in virulence between strains of T.
brucei involving different host pathways. The fact that different
pathways are involved, rather than a simple difference in the
magnitude of expression of the same pathways, is a novel
finding in host-parasite dynamics. The conclusion that the bal-
ance of the innate immune response is crucial to disease out-
come has intriguing parallels with studies examining the abil-
ities of different mouse strains or cattle breeds to tolerate
infection with trypanosomes, where similar conclusions have
been drawn (59, 60). These results suggest that control of
trypanosome infection should not be analyzed solely from the
viewpoint of the host, but that parasite genetic diversity also
has to be considered as a determinant of disease progression.
In the future, therefore, it will be important to study different
host-parasite genotype combinations, as the role of a particular
host pathway may depend on both the host and parasite ge-
netic backgrounds. The observed differences in pathology also
open up the possibility of identifying the parasite genes that
are responsible, for example, by using a forward genetic ap-
proach, as has been employed in Toxoplasma gondii (70, 78,
80), particularly as a genetic map exists for a cross using the
strains involved in this study (40, 47). The findings also obvi-
ously have implications for the use of genetic improvement by
selective breeding of cattle for trypanotolerance, as any breed-
ing must take into account the ability of animals to cope with
the range of trypanosome virulence that is undoubtedly
present in the field.
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